A 12-week randomised, double-blinded, placebo-controlled human trial to compare the efficacy and safety of Panax ginseng berry extract and placebo on glycemic control
Not Applicable
Active, not recruiting
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0001589
- Lead Sponsor
- AmorePacific
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age 20-75 years with fasting glucose 100~140 mg/dL
Exclusion Criteria
Abnormal lipid profile values
Acute/chronic inflammation
Treated with corticosteroid within past 4 weeks
Severe acute Cardiovascular disease such as Heart failure, myocardial infarction, stroke
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood glucose
- Secondary Outcome Measures
Name Time Method blood insulin